Discovery Phase
• High-throughput screening
• Kill fast compound
• Organs-on-chip platforms
Our Partnership Solutions to address Discovery, Pre-clinical and Clinical phases to deeply accelerate drug development.
To Discovery to Clinical phases.
Our Partnership Solutions to provide predictive datas on toxicity, efficacy and modes of action in discovery, preclinical or clinical phases.
Kill-fast & Go-fast your compound with our high-throughput organs-on-chip platform.
At NETRI we have developed various microfluidic architectures to provide human-relevant data early in the treatment development and to understand the mode of action of molecule at a deeper level.
All our devices are in NeoBento format which allows to be high throughput, high relevant, reproducible, data rich and to gain confidence in order to provide you high volumes for internal NOK.
Translate you datas to usable outputs and define the efficacy and mode of action of your drugs with our reference compound library and our human based assays co-development.
At NETRI we offer a full support services to set up our customers with full in-house organs-on-chip capabilities. We have accumulated an in-depth expertise by performing scientific projects in Neurosciences (pain, neurological disorders…), leading to the creation of a digital library with reference compound.
R&D Services
Human based assays co-development:
Pre-define your cohort with our heterogeneous broad-spectrum screening and our specific population screening.
At NETRI we offer a full support services to set up our customers with full in-house organs-on-chip capabilities. We have accumulated an in-depth expertise by performing scientific projects in Neurosciences (pain, neurological disorders…), leading to the creation of a digital library with reference compound.
We can work as your remote « internal » laboratory.
We define and estimate :
You monitor, manage and adapt: